IMU Biosciences raises £11.5 million Series A

IMU Biosciences secures £11.5 million in Series A funding to revolutionise immune powered precision medicine.

Read More

Molten Ventures leads $16.5m Series B in Morressier to lead the fight for research integrity

Molten Ventures today announces that it has led a Series B funding round of $16.5m in Morressier.

Read More